Yejin Kim

Yejin Kim is a prominent inventor based in Daejeon, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. Her work focuses on addressing critical health issues such as diabetes and neurodegenerative diseases.

Latest Patents

Yejin Kim holds a patent for a pharmaceutical composition that includes sustained-release microspheres containing a GLP-1 analogue or its pharmaceutically acceptable salt. This invention is particularly useful for the prevention and treatment of diabetes, preservation of beta-cell function, high blood pressure, hyperlipidemia, obesity, non-alcoholic steatohepatitis, and neurodegenerative diseases like Alzheimer's and Parkinson's. The sustained-release microsphere formulation effectively minimizes the initial burst of the drug, thereby reducing potential side effects and enhancing patient comfort during administration. She has 1 patent to her name.

Career Highlights

Yejin Kim has established herself as a key figure in pharmaceutical innovation. Her research and development efforts have led to advancements in drug formulations that prioritize patient safety and efficacy. She is dedicated to improving therapeutic outcomes through her innovative approaches.

Collaborations

Yejin collaborates with talented professionals in her field, including Yongha Na and Dongpil Won. These partnerships enhance her research capabilities and contribute to the success of her projects.

Conclusion

Yejin Kim is a trailblazer in the pharmaceutical industry, with her innovative work paving the way for new treatments for various health conditions. Her dedication to improving drug delivery systems exemplifies her commitment to advancing medical science.

Profile summary based on public USPTO records.